Does ENALAPRIL Cause Malignant neoplasm progression? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Malignant neoplasm progression have been filed in association with ENALAPRIL (Enalapril maleate oral solution). This represents 0.2% of all adverse event reports for ENALAPRIL.
13
Reports of Malignant neoplasm progression with ENALAPRIL
0.2%
of all ENALAPRIL reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ENALAPRIL?
Of the 13 reports, 4 (30.8%) resulted in death, 5 (38.5%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENALAPRIL. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ENALAPRIL Cause?
Acute kidney injury (916)
Drug ineffective (599)
Hypotension (556)
Dyspnoea (514)
Hypertension (451)
Hyperkalaemia (448)
Drug interaction (441)
Angioedema (412)
Off label use (347)
Diarrhoea (342)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ENALAPRIL Alternatives Have Lower Malignant neoplasm progression Risk?
ENALAPRIL vs ENALAPRIL\HYDROCHLOROTHIAZIDE
ENALAPRIL vs ENALAPRIL\LERCANIDIPINE
ENALAPRIL vs ENASIDENIB
ENALAPRIL vs ENBREL
ENALAPRIL vs ENCORAFENIB